Canandaigua National Corp’s Pfizer PFE Stock Holding History

Canandaigua National Corp’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.48M	Buy	+159,496	New	+$4.25M	0.4%	53
2022 Q4	$10.4M	Buy	203,735 +6,983	+4%	+$335K	1.77%	10
2022 Q3	$8.61M	Buy	196,752 +3,189	+2%	+$155K	1.53%	13
2022 Q2	$10.1M	Sell	193,563 -2,047	-1%	-$104K	1.8%	8
2022 Q1	$10.1M	Buy	195,610 +46,253	+31%	+$2.4M	1.54%	11
2021 Q4	$8.82M	Sell	149,357 -404	-0.3%	-$20K	1.3%	14
2021 Q3	$6.44M	Sell	149,761 -4,114	-3%	-$182K	1.05%	22
2021 Q2	$6.03M	Sell	153,875 -2,231	-1%	-$86.8K	0.98%	28
2021 Q1	$5.66M	Sell	156,106 -4,645	-3%	-$165K	0.96%	29
2020 Q4	$5.92M	Sell	160,751 -37,410	-19%	-$1.37M	1.04%	23
2020 Q3	$6.9M	Sell	198,161 -17,930	-8%	-$629K	1.22%	19
2020 Q2	$6.7M	Buy	+216,091	New	+$7.34M	1.23%	20

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Canandaigua National Corp's PFE Position: Q1 2026 in Review

Canandaigua National Corp opened a new position in Pfizer (PFE) in Q1 2026: 159,496 shares worth $4.48M. The stake represents 0.4% of the portfolio and ranks #53 among its holdings. This is a return to the name: Canandaigua National Corp previously reported a position in PFE as recently as Q4 2022.

Canandaigua National Corp first reported a position in PFE in Q2 2020 and has held it in 12 quarters since. The position peaked at $10.4M in Q4 2022. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Canandaigua National Corp held 159,496 shares of Pfizer worth $4.48M as of Q1 2026.
Pfizer was a new Canandaigua National Corp position in Q1 2026.
Pfizer made up 0.4% of Canandaigua National Corp's portfolio in Q1 2026, its #53 holding.
Canandaigua National Corp first reported a position in Pfizer in Q2 2020 and has held it in 12 quarters since.
Canandaigua National Corp's Pfizer position peaked at $10.4M in Q4 2022.
2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Canandaigua National Corp's 13F filing for Q1 2026, filed 8 Apr 2026.